Calcineurin pathway inhibition: A novel antifungal strategy

Journal of Invasive Fungal Infections

Volumn 4, Issue 1, 2010, Pages 1-7

  Steinbach, William J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CASPOFUNGIN; CYCLOSPORIN A; TACROLIMUS;

ANTIFUNGAL ACTIVITY; ASPERGILLUS FUMIGATUS; CENTRAL NERVOUS SYSTEM INFECTION; CRYPTOCOCCUS NEOFORMANS; DRUG POTENTIATION; FUNGAL VIRULENCE; FUNGUS GROWTH; GENE DELETION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INFECTION RISK; REVIEW; RNA TRANSLATION;

EID: 83455210995     PISSN: 17533783     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Neofytos D, Horn D, Anaissie E et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 2009;48:265-73.
2. Edmond MB, Wallace SE, McClish DK et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999;29:239-44. (Pubitemid 29380177)
3. Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin North Am 2006;20:507-44. (Pubitemid 44375117)
4. Marr KA, Carter RA, Crippa F et al. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002;34:909-17. (Pubitemid 34229758)
5. McNeil MM, Nash SL, Hajjeh RA et al. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis 2001;33:641-7. (Pubitemid 32762937)
6. Pappas PG, Rotstein CM, Betts RF et al. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis 2007;45:883-93. (Pubitemid 47580382)
7. Bicanic T, Meintjes G, Wood R et al. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. Clin Infect Dis 2007;45:76-80. (Pubitemid 46984619)
8. Herbrecht R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-15. (Pubitemid 34851833)
9. Maertens J, Raad I, Petrikkos G et al. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 2004;39:1563-71. (Pubitemid 39578526)
10. Wilson LS, Reyes CM, Stolpman M et al. The direct cost and incidence of systemic fungal infections. Value Health 2002;5:26-34. (Pubitemid 34160368)
11. Johnson MD, Kleinberg M, Danziger L et al. Pharmacoeconomics of antifungal pharmacotherapy - challenges and future directions. Expert Opin Pharmacother 2005;6:2617-32. (Pubitemid 41824377)
12. Steinbach WJ, Stevens DA. Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis. Clin Infect Dis 2003;37:S157-87. (Pubitemid 37260461)
13. Cowen LE, Steinbach WJ. Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance. Eukaryotic Cell 2008;7:747-64. (Pubitemid 351968819)
14. Klee CB, Crouch TH, Krinks MH. Calcineurin: a calcium- and calmodulin-binding protein of the nervous system. Proc Natl Acad Sci USA 1979;76:6270-3. (Pubitemid 10163382)
15. Fox DS, Heitman J. Good fungi gone bad: the corruption of calcineurin. Bioessays 2002;24:894-903. (Pubitemid 35197585)
16. Steinbach WJ, Reedy JL, Cramer RA Jr et al. Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nat Rev Microbiol 2007;5:418-30. (Pubitemid 46780079)
17. Clipstone NA, Crabtree GR. Identification of calcineurin as a key signaling enzyme in T-lymphocyte activation. Nature 1992;357:695-7.
18. Hoflin JM, Potasman I, Baldwin JC et al. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med 1987;106:209-16. (Pubitemid 17009879)
19. Singh N, Avery RK, Munoz P et al. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis 2003;36:46-52. (Pubitemid 36099096)
20. Singh N, Heitman J. Antifungal attributes of immunosuppressive agents: new paradigms in management and elucidating the pathophysiologic basis of opportunistic mycoses in organ transplant recipients. Transplantation 2004;77:795-800. (Pubitemid 38436812)
21. Singh N, Alexander BD, Lortholary O et al. Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis 2007;195:756-64.
22. Steinbach WJ, Singh N, Miller JL et al. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients. Antimicrob Agents Chemother 2004;48:4922-5. (Pubitemid 39577709)
23. Reedy JL, Husain S, Ison M et al. Immunotherapy with tacrolimus (FK506) does not select for resistance to calcineurin inhibitors in Candida albicans isolates from liver transplant patients. Antimicrob Agents Chemother 2006;50:1573-7.
24. Blankenship JR, Singh N, Alexander BD. Cryptococcus neoformans isolates from transplant recipients are not selected for resistance to calcineurin inhibitors by current immunosuppressive regimens. J Clin Microbiol 2005;43:4.
25. Cruz MC, Goldstein AL, Blankenship JR et al. Calcineurin is essential for survival during membrane stress in Candida albicans. EMBO J 2002;21:546-59. (Pubitemid 34174036)
26. Bader T, Bodendorfer B, Schroppel K et al. Calcineurin is essential for virulence in Candida albicans. Infect Immun 2003;71:5344-54. (Pubitemid 37070782)
27. Blankenship JR, Wormley FL, Boyce MK et al. Calcineurin is essential for Candida albicans survival in serum and virulence. Eukaryotic Cell 2003;2:422-30. (Pubitemid 36774691)
28. Sanglard D, Ischer F, Marchetti O et al. Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence. Mol Microbiol 2003;48:959-76. (Pubitemid 36628262)
29. Blankenship JR, Heitman J. Calcineurin is required for Candida albicans to survive calcium stress in serum. Infect Immun 2005;73:5767-74. (Pubitemid 41193012)
30. Karababa M, Valentino E, Pardini G et al. CRZ1, a target of the calcineurin pathway in Candida albicans. Mol Microbiol 2006;59:1429-51.
31. Onyewu C, Wormley FL Jr, Perfect JR et al. The calcineurin target, Crz1, functions in azole tolerance but is not required for virulence of Candida albicans. Infect Immun 2004;72:7330-3. (Pubitemid 39552408)
32. Santos M, de Larrinoa IF. Functional characterization of the Candida albicans CRZ1 gene encoding a calcineurin-regulated transcription factor. Curr Genet 2005;48:88-100. (Pubitemid 41554564)
33. Marchetti O, Moreillon P, Entenza JM et al. Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes. Antimicrob Agents Chemother 2003;47:1565-70. (Pubitemid 36548538)
34. Marchetti O, Moreillon P, Glauser MP et al. Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans. Antimicrob Agents Chemother 2000;44:2373-81. (Pubitemid 30650882)
35. Onyewu C, Blankenship JR, Del Poeta M et al. Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. Antimicrob Agents Chemother 2003;47:956-64. (Pubitemid 36254221)
36. Becker JW, Rotonda J, McKeever BM et al. FK-506-binding protein: three dimensional structure of the complex with the antagonist L-685,818. J Biol Chem 1993;25:11335-9. (Pubitemid 23162330)
37. Odom A, Del Poeta M, Perfect J et al. The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein. Antimicrob Agents Chemother 1997;41:156-61. (Pubitemid 26428148)
38. Marchetti O, Entenza JM, Sanglard D et al. Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans. Antimicrob Agents Chemother 2000;44:2932-8.
39. Odom A, Muir S, Lim E et al. Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J 1997;16:2576-89. (Pubitemid 27226197)
40. Fox DS, Cruz MC, Sia RA et al. Calcineurin regulatory subunit is essential for virulence and mediates interactions with FKBP12-FK506 in Cryptococcus neoformans. Mol Microbiol 2001;39:835-49. (Pubitemid 32176330)
41. Mody CH, Toews GB, Lipscomb MF. Cyclosporin A inhibits the growth of Cryptococcus neoformans in a murine model. Infect Immun 1988;56:7-12. (Pubitemid 18032119)
42. Mody CH, Toews GB, Lipscomb MF. Treatment of murine cryptococcosis with cyclosporin-A in normal and athymic mice. Am Rev Respir Dis 1989;139:8-13. (Pubitemid 19030414)
43. Cruz MC, Del Poeta M, Wang P et al. Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin. Antimicrob Agents Chemother 2000;44:143-9. (Pubitemid 30010685)
44. Cruz MC, Fox DS, Heitman J. Calcineurin is required for hyphal elongation during mating and haploid fruiting in Cryptococcus neoformans. EMBO J 2001;20:1020-32. (Pubitemid 32186793)
45. Kraus PR, Nicholls CB, Heitman J. Calcium and calcineurin-independent roles for calmodulin in Cryptococcus neoformans morphogenesis and high-temperature growth. Eukaryot Cell 2005;4:1079-87.
46. Gorlach J, Fox DS, Cutler NS et al. Identification and characterization of a highly conserved calcineurin binding protein, CBP1/calcipressin in Cryptococcus neoformans. EMBO J 2000;19:3618-29.
47. Fox DS, Heitman J. Calcineurin-binding protein Cbp1 directs the specificity of calcineurin-dependent hyphal elongation during mating in Cryptococcus neoformans. Eukaryotic Cell 2005;4:1526-38. (Pubitemid 41339108)
48. Rasmussen C, Garen C, Brining S et al. The calmodulin-dependent protein phosphatase catalytic subunit (calcineurin A) is an essential gene in Aspergillus nidulans. EMBO J 1994;13:2545-52. (Pubitemid 24188387)
49. Rasmussen C, Means RL, Lu KP et al. Characterization and expression of the unique calmodulin gene of Aspergillus nidulans. J Biol Chem 1990;265:13767-75.
50. Lu KP, Rasmussen CD, May GS et al. Cooperative regulation of cell proliferation by calcium and calmodulin in Aspergillus nidulans. Mol Endocrinol 1992;6:365-74.
51. Juvvadi PR, Arioka M, Nakajima H et al. Cloning and sequencing analysis of cnaA gene encoding the catalytic subunit of calcineurin from Aspergillus oryzae. FEMS Microbiol Lett 2001;204:169-74. (Pubitemid 33000052)
52. Juvvadi PR, Kuroki Y, Arioka M et al. Functional analysis of the calcineurin-encoding gene cnaA from Aspergillus oryzae: evidence for its putative role in stress adaptation. Arch Microbiol 2003;179:416-22.
53. Derkx PM, Madrid SM. The Aspergillus niger cypA gene encodes a cyclophilin that mediates sensitivity to the immunosuppressant cyclosporin A. Mol Genet Genomics 2001;266:527-36.
54. High KP. The antimicrobial activities of cyclosporine, FK506, and rapamycin. Transplantation 1994;57:1689-700. (Pubitemid 24206405)
55. Bell NP, Karp CL, Alfonso EC et al. Effects of methylprednisolone and cyclosporine A on fungal growth in vitro. Cornea 1999;18:306-13. (Pubitemid 29205557)
56. Kontoyiannis DP, Lewis RE, Osherov N et al. Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species. J Antimicrob Chemother 2003;51:313-6. (Pubitemid 36231150)
57. Berenguer J, Allende MC, Lee JW et al. Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone- induced immunosuppression. Am J Respir Crit Care Med 1995;152:1079-86.
58. High KP, Washburn RG. Invasive aspergillosis in mice immunosuppressed with cyclosporin A, tacrolimus (FK506), or sirolimus (rapamycin). J Infect Dis 1997;175:222-5. (Pubitemid 27020854)
59. Steinbach WJ, Cramer Jr RA, Perfect BZ et al. Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus. Eukaryotic Cell 2006;5:1091-103. (Pubitemid 44100707)
60. da Silva Ferreira ME, Kress MR, Savoldi M et al. The akuB(KU80) mutant deficient for nonhomologous end joining is a powerful tool for analyzing pathogenicity in Aspergillus fumigatus. Eukaryotic Cell 2005;5:207-11. (Pubitemid 43113467)
61. Ferreira ME, Heinekamp T, Hartl A et al. Functional characterization of the Aspergillus fumigatus calcineurin. Fungal Genet Biol 2007;44:219-30. (Pubitemid 46186067)
62. Boustany LM, Cyert MS. Calcineurin-dependent regulation of Crz1p nuclear export requires Msn5p and a conserved calcineurin docking site. Genes Dev 2002;16:608-19. (Pubitemid 34212493)
63. Cyert MS. Calcineurin signaling in Saccharomyces cerevisiae: how yeast go crazy in response to stress. Biochem Biophys Res Commun 2003;311:1143-50. (Pubitemid 37393437)
64. Matheos DP, Kingsbury TJ, Ahsan US et al. Tcn1p/Crz1p, a calcineurin-dependent transcription factor that differentially regulates gene expression in Saccharomyces cerevisiae. Genes Dev 1997;11:3445-58. (Pubitemid 28023966)
65. Mendizabal I, Pascual-Ahuir A, Serrano R et al. Promoter sequences regulated by the calcineurin-activated transcription factor Crz1 in the yeast ENA1 gene. Mol Genet Genomics 2001;265:801-11. (Pubitemid 32763294)
66. Polizotto RS, Cyert MS. Calcineurin-dependent nuclear import of the transcription factor Crz1p requires Nmd5p. J Cell Biol 2001;154:951-60. (Pubitemid 34286175)
67. Stathopoulos AM, Cyert MS. Calcineurin acts through the CRZ1/TCN1-encoded transcription factor to regulate gene expression in yeast. Genes Dev 1997;11:3432-44. (Pubitemid 28023965)
68. Stathopoulos-Gerontides A, Guo JJ, Cyert MS. Yeast calcineurin regulates nuclear localization of the Crz1p transcription factor through dephosphorylation. Genes Dev 1999;13:798-803. (Pubitemid 29169839)
69. Yoshimoto H, Saltsman K, Gasch AP et al. Genome-wide analysis of gene expression regulated by the calcineurin/Crz1p signaling pathway in Saccharomyces cerevisiae. J Biol Chem 2002;277:31079-88. (Pubitemid 34970813)
70. Cramer RA, Perfect BZ, Pinchai N et al. Calcineurin target CrzA regulates conidial germination, hyphal growth, and pathogenesis of Aspergillus fumigatus. Eukaryotic Cell 2008;7:1085-97. (Pubitemid 351969323)
71. Guerini D, Klee CB. Cloning of human calcineurin A: evidence for two isoenzymes and identification of a polyproline structural domain. Proc Natl Acad Sci USA 1989;86:9183-7. (Pubitemid 20010389)
72. Northrop JP, Ho SN, Chen L et al. NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 1994;369:497-502.
73. Pinchai N, Perfect BZ, Juvvadi PR et al. The Aspergillus fumigatus calcipressin cbpA is involved in hyphal growth and calcium homeostasis. Eukaryot Cell 2009;8:511-9.
74. Hilioti Z, Cunningham KW. The RCN family of calcineurin regulators. Biochem Biophys Res Commun 2003;311:1089-93. (Pubitemid 37393431)
75. Strausberg RL, Feingold EA, Grouse LH et al. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci USA 2002;99:16899-903. (Pubitemid 36034070)
76. Steinbach WJ, Schell WA, Blankenship JR et al. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus. Antimicrob Agents Chemother 2004;48:1664-69. (Pubitemid 38544372)
77. Steinbach WJ, Cramer RA, Perfect BZ et al. Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus. Antimicrob Agents Chemother 2007;51:2979-81. (Pubitemid 47206239)
78. Chiou CC, Mavrogiorgos N, Tillem E et al. Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus. Antimicrob Agents Chemother 2001;45:3310-21. (Pubitemid 33107840)
79. Ganesan LT, Manavathu EK, Cutright JL et al. In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus. Clin Microbiol Infect 2004;10:961-6. (Pubitemid 39562462)
80. Perfect JR, Wright KA, Hector RF. Synergistic interaction of nikkomycin and cilofungin against diverse fungi. In: Yamaguchi H, Kobayashi GS, Takahashi H, eds. Recent progress in antifungal chemotherapy. New York, NY: Marcel-Dekker, Inc.;1992:369-79.
81. Stevens DA. Drug interaction studies of a glucan synthase inhibitor (LY303366) and a chitin synthase inhibitor (nikkomycin Z) for inhibition and killing of fungal pathogens. Antimicrob Agents Chemother 2000;44:2547-8. (Pubitemid 30650914)